BOSTON (AP) — BOSTON (AP) — Ironwood Pharmaceuticals Inc. (IRWD) on Thursday reported second-quarter profit of $23.6 million.
On a per-share basis, the Boston-based company said it had net income of 14 cents.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 2 cents per share.
The drugmaker posted revenue of $85.2 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $61.8 million.
Ironwood expects full-year revenue in the range of $260 million to $290 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IRWD at https://www.zacks.com/ap/IRWD
/AI%20(artificial%20intelligence)/Data%20Center%20by%20Caureem%20via%20Shutterstock%20(2).jpg)
/PayPal%20Holdings%20Inc%20HQ%20photo-by%20bennymarty%20via%20iStock.jpg)
/Micron%20Technology%20Inc_%20logo%20on%20building-by%20vzphotos%20vis%20iStock.jpg)
